These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 17274376
1. [Analysis of EGFR mutations in 176 cases of non-small cell lung cancer]. Dong QG, Han BH, Huang JS, Yang LM, Huang J, Zhao CY, Lu LQ. Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):686-90. PubMed ID: 17274376 [Abstract] [Full Text] [Related]
3. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes]. Zhou CC, Zhou SW, Pan H, Su B, Gao ZQ. Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):119-23. PubMed ID: 17645848 [Abstract] [Full Text] [Related]
4. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system]. Zhang J, Liang ZY, Zeng X, Wu SF, Gao J, Liu TH. Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645 [Abstract] [Full Text] [Related]
5. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer]. Fan MJ, Li HG, Lü ZQ, Zhang HZ, Shen XM. Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547 [Abstract] [Full Text] [Related]
7. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Huang SF, Liu HP, Li LH, Ku YC, Fu YN, Tsai HY, Chen YT, Lin YF, Chang WC, Kuo HP, Wu YC, Chen YR, Tsai SF. Clin Cancer Res; 2004 Dec 15; 10(24):8195-203. PubMed ID: 15623594 [Abstract] [Full Text] [Related]
9. [Status and clinicopathologic implication of epidermal growth factor receptor mutation in non-small cell carcinoma of lung]. Xu ML, Liu Y, Zhong HH, Wu BQ. Zhonghua Bing Li Xue Za Zhi; 2007 Jul 15; 36(7):453-6. PubMed ID: 17845757 [Abstract] [Full Text] [Related]
10. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients. Das BR, Bhaumik S, Ahmad F, Mandsaurwala A, Satam H. Pathol Oncol Res; 2015 Jul 15; 21(3):675-87. PubMed ID: 25637496 [Abstract] [Full Text] [Related]
11. Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients. Haghgoo SM, Khosravi A, Mortaz E, Pourabdollah-Toutkaboni M, Seifi S, Sabour S, Allameh A. Clin Biochem; 2017 Apr 15; 50(6):293-300. PubMed ID: 27923629 [Abstract] [Full Text] [Related]
12. [Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers]. Wang F, Fu S, Tang T, Deng L, Zhang X, Li YZ, Shao JY. Zhonghua Bing Li Xue Za Zhi; 2011 Oct 15; 40(10):664-6. PubMed ID: 22321543 [Abstract] [Full Text] [Related]
13. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component. Ohtsuka K, Ohnishi H, Fujiwara M, Kishino T, Matsushima S, Furuyashiki G, Takei H, Koshiishi Y, Goya T, Watanabe T. Cancer; 2007 Feb 15; 109(4):741-50. PubMed ID: 17238183 [Abstract] [Full Text] [Related]
14. [EGFR gene mutation status among lung cancer patients in China]. Li Q, Zhao YL, Hao HJ, Li XH. Zhonghua Zhong Liu Za Zhi; 2007 Apr 15; 29(4):270-3. PubMed ID: 17760253 [Abstract] [Full Text] [Related]
15. [Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer]. Wang S, Han XH, Li JL, Hu XS, Wang XY, Gui L, Zhao LD, Sun Y, Shi YK. Zhonghua Bing Li Xue Za Zhi; 2012 Aug 15; 41(8):530-3. PubMed ID: 23157744 [Abstract] [Full Text] [Related]
16. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations. Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y. Genes Chromosomes Cancer; 2012 Oct 15; 51(10):925-32. PubMed ID: 22736493 [Abstract] [Full Text] [Related]
17. EGFR and erbB2 mutation status in Japanese lung cancer patients. Sasaki H, Shimizu S, Endo K, Takada M, Kawahara M, Tanaka H, Matsumura A, Iuchi K, Haneda H, Suzuki E, Kobayashi Y, Yano M, Fujii Y. Int J Cancer; 2006 Jan 01; 118(1):180-4. PubMed ID: 16003726 [Abstract] [Full Text] [Related]
18. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P. J Thorac Oncol; 2009 Jan 01; 4(1):12-21. PubMed ID: 19096301 [Abstract] [Full Text] [Related]
19. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M. Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113 [Abstract] [Full Text] [Related]
20. [Detection of epidermal growth factor receptor gene mutations and its clinical significance in non-small cell lung cancers]. Zhao J, Zhu Y, Zhang L, Yu YW, Zheng JM. Zhonghua Bing Li Xue Za Zhi; 2011 Oct 14; 40(10):671-4. PubMed ID: 22321545 [Abstract] [Full Text] [Related] Page: [Next] [New Search]